ICT Completed Series B Financing, CEC Capital Served as the Exclusive Financial Advisor

Innovative Cellular Therapeutics (ICT) announced that the company had completed its Series B financing of RMB 180 million.  Investors in this new round included Volcanics Venture, GTJA Investment Group, SBCVC, Dunhou Capital and Withtruth Capital. The company completed its Series A financing in 2016 with investments from CDH and I-Bridge Capital.

CEC Capital served as the Exclusive Financial Advisor to ICT in this new round.